Data as-of 2026-07-24 close (Friday settled close).

TMO crossed into overbought this week — RSI 71.0, the only name above 70 in this 21-ticker cut, still flagged thesis-intact. HROW moved the opposite direction: RSI 66.6 → 39.9, a -17.58% single-week drop that erased its spot among the sector's leaders. ISRG stayed pinned in a collapse regime at RSI 31.4, -45.0% off its 52-week high, while MRK and JNJ both climbed into the low-to-mid 60s — MRK's regime classifier now reads an outright breakout, just -0.96% off its own 52-week high.

Source: healthcare.json (the broader 21-name universe, not the narrower healthcare-scan.json cut). Latest bar 2026-07-24 for every name in this cut. Prior scan: 2026-07-17-healthcare-scan.

TMO is this session's clearest single-name story. RSI climbed to 71.0 — the only name in this cut above the overbought threshold — up 6.72% over the past week and 15.45% over 30 days (change7d, change30d per healthcare.json), with its thesis flag still reading "intact." HROW moved the opposite direction, dropping RSI from 66.6 to 39.9 on a -17.58% single-week decline (change7d) that erased its place among the sector's best-performing names.

ISRG remains the sector's most structurally broken large-cap. RSI sits at 31.4, essentially unchanged from the 30.2 flagged two scans ago, with the price now -45.02% off its 52-week high — worse than the -42.8% read on July 17 — and the regime classifier still reading "collapse" despite an "intact" thesis flag on file.

MRK and JNJ both climbed into the low-to-mid 60s this week: MRK's RSI moved 58.1 → 62.4, and its regime classifier now reads "breakout" — the strongest structural read of any name in the cut, just -0.96% off its 52-week high and up 17.97% over 3 months. JNJ moved 54.5 → 62.8, up 9.29% over 30 days.

Away from those extremes, a broad middle of the sector cooled from a more extended prior read: GILD, DXCM, UNH, VEEV, CVS, BIIB, VRTX, and PFE all pulled back into the RSI 46-62 range this week, down from the RSI 53-69 range they carried on July 17 — a delayed version of the same broad-cooling pattern this session's chip-sector cut showed a week earlier.

• TMO crossed into overbought. RSI 62.3 → 71.0, +15.45% over 30 days — the only name in the cut now above the 70 threshold, thesis still marked "intact."
• HROW had the sector's worst single week. RSI 66.6 → 39.9, -17.58% over the past week — the biggest reversal in the cut.
• ISRG remained the sector's most broken large-cap. RSI 30.2 → 31.4, essentially flat, but the price kept deteriorating (-45.02% off its 52-week high vs -42.8% two scans ago).
• MRK climbed into a "breakout" regime. RSI 58.1 → 62.4, now just -0.96% off its own 52-week high.
• JNJ improved meaningfully. RSI 54.5 → 62.8, +9.29% over 30 days.
• MRNA kept sliding. RSI 45.9 → 36.7, -12.54% over the past week — the same direction flagged last scan.
• A broad middle of the sector cooled from prior extension. GILD (56.9 → 47.9), DXCM (58.9 → 47.4), UNH (58.4 → 51.6), VEEV (65.3 → 53.0), CVS (68.5 → 61.6), PFE (53.6 → 46.6) all pulled back.
• ZTS remains broken. RSI 46.9 → 45.5, still in a "collapse" regime, -53.53% off its 52-week high.
• ABT held its leadership position. RSI 67.2 → 68.3, still climbing without extending into overbought.
• Universe unchanged. Same 21 tickers as the July 17 healthcare.json cut — no composition change.

RSI measures how stretched a stock is over the past 14 sessions — under 30 is oversold, over 70 is overbought/extended. vs SMA20 is the price gap to the 20-day average. vs VWAP is the premium over the average price paid by current holders — a useful gut check on how much of a move is unrealized gain that could get sold into weakness. Trend combines direction/strength with a cross signal: GC (golden cross) is structurally healthier than DC (death cross). A stock at a low RSI while the regime classifier reads "collapse" — like ISRG and ZTS here — means the price move hasn't been confirmed by the underlying structure; treat it as "watch," not "buy."

None.

ISRG (31.4), MRNA (36.7), HROW (39.9). Three names — HROW is new to this band after its -17.6% single-week break.

• Weak / unresolved (RSI 41-49): ZTS, PFE, DXCM, GILD, GH, VRTX. ZTS remains the standout for how broken it is (-53.5% from its 52-week high, strong-down DC, "collapse" regime).
• Basing / cleanest accumulate (RSI 50-58): BIIB, UNH, VEEV, MDT, SYK, LLY. None extended, none broken.
• Momentum (RSI 61+): CVS, MRK, JNJ, AMGN, ABT, TMO. TMO alone crossed the overbought line at 71.0; MRK's "breakout" regime read is the strongest structural signal in the cut.

• TMO just crossed into overbought for the first time in this cut — does the thesis-intact name keep running, or cool off from here?
• HROW cracked hard this week (66.6 → 39.9, -17.6% over the past week) after months of extension — is this a normal give-back or the start of a real reversal?
• MRK's regime classifier now reads "breakout," just -1.0% off its 52-week high — does it confirm with a golden cross, or is this a false extension?
• ISRG and ZTS remain the sector's two structurally broken names — any sign either finds a floor, or does the collapse regime keep deepening in both?

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-24 close — healthcare.